Scientific update
High-Throughput Label-free Cell Interaction Studies
At the ASCB | EMBO 2017 meeting, we introduced z-Movi®, a new platform for cell interaction studies.
This new method enables direct and label-free screening and sorting of thousands of cells based on their interaction with cell or protein targets. z-Movi® is a breakthrough technology for research and development of personalized therapies, including immunotherapy. It is the first platform able to directly measure the strength of interaction, or avidity, between cells with specific targets and sort cells of interest, in a high-throughput and label-free manner.
Want to learn more about z-Movi®? Contact us for more information, a demo or a quote.
No items found.
No items found.
No items found.
Text Link
Enhancing efficacy against clear cell renal cell carcinoma through format-tuning of bispecific T cell engagers
Scientific update
January 29, 2025
01-01-20
Text Link
Study using CTFM Published in Nature Communications
Scientific update
June 15, 2016
01-01-20
Text Link
AFS 2.0 Paper Published in Methods
Scientific update
June 5, 2016
01-01-20
Text Link
Paper Using LUMICKS Technology Published in Nature
Scientific update
July 21, 2016
01-01-20
No items found.
See more. Know more.
We empower the academic and pharmaceutical communities with cutting-edge technologies to deeply understand the mechanisms of life and disease, driving the discovery and development of life-saving therapies
All products and technologies are for Research Use Only (RUO) except when specifically noted